.

Octanine F

Human coagulation factor IX

 

  • Composition
    Each vial with lyophilized powder contains the following active pharmaceutical ingredient:
    Octanine F 250: 250 IU of Human coagulation factor IX.
    Octanine F 500: 500 IU of Human coagulation factor IX.


  • Indications
    Treatment and prophylaxis of bleeding in patients with haemophilia B (congenital factor IX deficiency) or acquired deficiency of Factor IX.

  • Contraindications
    - Hypersensitivity to the active pharmaceutical ingredient or to any other component of the product.
    - Heparin induced thrombocytopenia (HIT type II).

  • Presentation
    Octanine F 250: box containing one vial with lyophilized powder + one vial with 5 mL of solvent + the injection kit.
    Octanine F 500: box containing one vial with lyophilized powder + one vial with 10 mL of solvent + the injection kit.